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Abstract Infection with soil-transmitted gastrointestinal
parasites, such as Trichuris trichiura, affects more than a
billion people worldwide, causing significant morbidity
and health problems especially in poverty-stricken devel-
oping countries. Despite extensive research, the role of
the immune system in triggering parasite expulsion is
incompletely understood which hinders the development
of anti-parasite therapies. Trichuris muris infection in
mice serves as a useful model of T. trichiura infection
in humans and has proven to be an invaluable tool in
increasing our understanding of the role of the immune
system in promoting either susceptibility or resistance to
infection. The old paradigm of a susceptibility-associated
Th1 versus a resistance-associated Th2-type response has
been supplemented in recent years with cell populations
such as novel innate lymphoid cells, basophils, dendritic
cells and regulatory T cells proposed to play an active role
in responses to T. muris infection. Moreover, new immune-
controlled mechanisms of expulsion, such as increased epi-
thelial cell turnover and mucin secretion, have been described
in recent years increasing the number of possible targets for
anti-parasite therapies. In this review, we give a comprehen-
sive overview of experimental work conducted on the T. muris
infection model, focusing on important findings and the most
recent reports on the role of the immune system in parasite
expulsion.
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Introduction
Soil-transmitted helminth (STH) infections, mainly trichur-
iasis, ascariasis and hookworm, affect more than a billion
people, especially in poverty-stricken areas in the develop-
ing world [1]. Trichuris trichiura alone is believed to infect
almost 800 million people worldwide, with the majority
being children [1]. Infected children show signs of malnu-
trition, stunted growth, intellectual retardation and educa-
tional deficits [2]. Moreover, infection during pregnancy
increases the risk of maternal anaemia and reduces infant
birth weight and survival [2]. The burden of diseases attrib-
uted to STHs is of great consequence to economic progress
of developing countries, trapping affected people and whole
communities in poverty. Therefore, increasing our under-
standing of how effector immune responses against STHs
are induced and controlled is pivotal for the development of
novel therapies.
In recent decades, studies on the gastrointestinal parasite
Trichuris muris, a mouse model of T. trichiura infection in
humans, have greatly contributed to our knowledge on
components of immune responses responsible for resistance
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and susceptibility to infection. Research conducted on T.
muris has presented us with novel explanations on how
the immune system induces parasite expulsion, which could
have broader application for new treatment development
against soil-transmitted parasite infections.
T. muris
Life cycle
Infection with T. muris occurs by the ingestion of infective eggs
that accumulate in the caecum (Fig. 1). Ninety minutes post
infection (p.i.), the first larvae (L1) hatch from eggs. Interest-
ingly, egg interaction with the bacterial microflora of the gut is
important for induction of parasite hatching [3]. Experimental-
ly, using laboratory-derived strains of bacteria, this process has
been shown to be dependent on bacterial type 1 fimbriae which
normally facilitate mannose-sensitive adherence of bacteria to
cells and mucosal surfaces. Culturing of T. muris eggs with
Escherichia coli strain which lacks a gene cluster responsible
for type 1 fimbriae expression resulted in severely impaired
parasite hatching [3]. In addition, mice treated with antibiotics
had reduced numbers of worms compared to untreated controls
[3]. Whilst the precise species of bacteria responsible for hatch-
ing in vivo remains to be defined, the data do provide an
explanation for why hatching occurs preferably in the
caecum—the main site of the intestinal microflora.
Upon hatching, L1 penetrate the caecum and proximal
colon wall, dwell in the epithelial layer and undergo threemore
moults to L2 (9–11 days p.i.), L3 (17 days p.i.) and L4 stage
(22 days p.i.). Moults may occur at slightly different time
points depending on the strain of the host. During larval
development, the parasite moves from solely within the epi-
thelial layer to extend into the gut lumen. By day 32 p.i., adult
worms are observed in the caecum and proximal colon of
infected mice. Interestingly, the anterior part of the worm is
buried in parasite-modified epithelial cells which form a struc-
ture resembling ‘syncitial tunnels’. Tilney et al. [4] have shown
via electron microscopy that T. muris lives in direct contact
with modified epithelial cell cytoplasm. Boring of the parasite
into epithelium causes the surrounding cells to rupture mainly
by affecting the lateral wall of cells. The apical and basal
surfaces of cells often remain intact leading to the creation of
‘tunnels’ in which the parasite dwells [4]. Eggs, which leave
the host organismwith faeces, need approximately 2 months to
embroynate and become infective (reviewed in [5]).
Host predispositions to infection—genetic background
and gender
Early studies on outbred and inbred strains of mice sug-
gested that the genetic background of the host was an
important element contributing to observed variation in
susceptibility to T. muris infection [5]. Indeed, it has been
shown that genes within the H-2 allele of the major
Fig. 1 Trichuris muris life
cycle. Infection occurs by the
ingestion of infective eggs
which hatch in the caecum
90 min post infection (p.i.)
releasing the first larvae (L1).
L1 penetrate the caecum and
proximal colon wall, dwell in
the epithelial layer and undergo
three more moults to L2 (9–
11 days p.i.), L3 (17 days p.i.)
and L4 stage (22 days p.i.). By
day 32 p.i. female and male
adult forms of T. muris can be
observed in the caecum and
proximal colon of infected
mice. Eggs, which leave the
host organism with faeces, need
2 months to embryonate and
become infective
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histocompatibility complex (MHC) and non-H-2 genes can
affect resistance to T. muris. Studies on two groups of
congenic strains have demonstrated that certain genetic
backgrounds are more resistant than others (e.g. mice on
the BALB genetic background are more resistant than mice
on B10 background) even if they share the same H-2 hap-
lotype [6]. Likewise, mice sharing certain ‘resistant’ H-2
alleles within the I-A region (H-2q, H-2b) expel parasites
faster than mice having a ‘susceptible’ H-2 phenotype (H-
2k, H-2d). The influence of these alleles was further modu-
lated by the differences in the D end of the H-2 complex
between these strains [7]. Therefore, the H-2 complex can
affect expulsion kinetics; however, genes from outside the
MHC complex play a dominant role in determining the
outcome of T. muris infection in mice. This is especially
evident in BALB/k and AKR mice, both sharing the H-2k
haplotype, with the former generating a resistant-associated
Th2 response followed by parasite expulsion and the latter
succumbing to chronic infection accompanied by the devel-
opment of a Th1 response [8]
Beside the genetic background influence on resistance to
T. muris infection, the gender of the host also affects the
efficiency of worm clearance. Studies by Bancroft et al.
have shown that IL-4-deficient BALB/c male and female
mice respond differently to T. muris infection, with males
developing a chronic infection whereas females expel the
worms (although later than wild-type controls) [9]. Further
research has demonstrated that this difference in expulsion
kinetics between genders is IL-13-dependent, since treat-
ment of female IL-4 KO mice with anti-IL-13 antibody
resulted in a lack of parasite clearance and administration
of recombinant IL-13 restored a resistant phenotype in IL-4
KO male mice [9]. Interestingly, neutralization of IFN-γ
resulted in normal parasite expulsion in both female and
male IL-4 KO mice [10]. Similar differences in parasite
expulsion have also been observed in TNF-α receptor KO
mice (p55/p75 KO mice), where female mice are resistant to
infection whereas males become chronically infected [11].
Moreover, similar to IL-4 KO mice, neutralization of IL-13
in female p55/p75 KO mice rendered them susceptible to
infection and administration of recombinant IL-13 to male
p55/p75 KO animals restored parasite expulsion [11]. Fur-
ther studies on sex steroid hormones have revealed that
male-associated dihydrotestosterone can decrease the ability
of dendritic cells (DCs) to activate T cells and also skew T
cell differentiation towards a Th1-type response via IL-18-
dependent mechanisms [12]. Conversely, the female-related
hormone 17-β-estradiol (E2) seems to enhance the genera-
tion of a Th2 response, at least in vitro [12]. These differ-
ences in sex hormones and their ability to affect the
development of immune responses to T. muris should be
considered a contributing factor in the variation in resistance
to infection with this parasite. Taken together, both host
genetic background and gender can greatly influence the
type of immune responses generated against T. muris and
subsequent parasite expulsion.
Infective dose
Apart from host genetic background and gender, the size of
infective dose and parasite genetics can also influence the
variation in susceptibility to infection with T. muris. It has
been demonstrated that decreasing the infective dose can
alter the polarization of the immune response favouring the
development of a susceptibility-associated Th1 immune re-
sponse. Normally resistant BALB/k mice when infected
with less than 40 T. muris eggs (low dose) instead of 400
eggs (high dose) develop chronic infection [13]. Moreover,
only high dose infection can render mice resistant to subse-
quent high and low dose challenge infections [14].
In addition to differences in host immune responses to
low and high antigen load, different isolates of T. muris can
also elicit distinct reactions from the immune system of the
host. There are three laboratory-used isolates of T. muris: E
(Edinburgh), J (Japan) and S (Sobreda) isolates [15]. It has
been shown that B10.BR, CBA and C57BL/10 mice, nor-
mally resistant to infection with both E and J isolates,
develop chronic infection when infected with S isolate [15,
16]. This was related to increased Th1 and decreased Th2
responses in S isolate-infected mice reflected in higher
levels of IFN-γ and Th1-associated IgG2a production [15,
16]. On the other hand, mice infected with E or J isolate
produced Th2-associated IL-5 and had higher levels of Th2-
associated IgG1 in the serum [16]. The same kinetics of
expulsion has been also observed for C57BL/6 mice which
expel E isolate normally but develop chronic infection when
infected with S isolate [17]. Here susceptibility to T. muris
has been associated with increased numbers of regulatory T
cells (Tregs) in the gut of mice infected with S but not E
isolate. It has been therefore suggested that Tregs can inhibit
the development of protective immunity and promote chron-
ic infection [17].
Immune responses to T. muris infection
The type of immune response generated against T. muris is
critical in mediating either susceptibility or resistance to
infection. The development of a Th2-type of response is
associated with fast parasite expulsion whereas a Th1 re-
sponse is linked to establishment of chronic infection and
increased immunopathology. The use of different mouse
strains and gene knockout animals has been crucial in de-
termining important cellular and molecular pathways of
importance during T. muris infection (see Table 1 for sum-
mary). In this section, we discuss cells and molecules found
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to be important in the generation of immune responses to T.
muris and their role in promoting and hampering parasite
expulsion. .
Components of the immune response to T. muris
T cells
T cells were shown to be important in mediating T. muris
expulsion as early as 1983 by Lee et al. In these experi-
ments, transfer of T cell-enriched but not B cell-enriched
populations from T. muris infected donors into naive recip-
ients transferred immunity to infection [18]. In addition, it
has been demonstrated that congenitally athymic mice
(Nude mice), which lack T cells, are susceptible to T. muris
infection [19]. However, worm expulsion could be observed
in Nude mice after splenocyte transfer. Moreover, transfer of
mesenteric lymph node (MLN) cells or thymocytes also
partially restored a resistant phenotype in these mice [19].
Studies on different subpopulations of T cells have brought
further insight into the importance of T cells during T. muris
infection, showing that depletion of CD4+ T cells but not
CD8+ T cells or NK1.1+ natural killer T cells with neutral-
izing antibodies resulted in susceptibility to infection
[20–22]. Additionally, adoptive transfer of CD4+ T cells
from resistant BALB/c mice into severe combined immu-
nodeficiency (SCID) mice, which lack the adaptive arm of
the immune system and therefore are susceptible to infec-
tion, resulted in worm expulsion proving that CD4+ T cells,
and not CD8+ T cells or B cells, are crucial for the devel-
opment of protective immunity to T. muris [23]. It has been
further demonstrated that CD4+ T cells are most effective
against larval stages of the parasite and that they act locally
at the site of infection, since inhibition of the gut homing
receptors β7 and αE integrins and the gut homing ligand
MAdCAM-1 completely abrogates the ability of transferred
Table 1 A summary of differences in immune responses to T. muris between different mouse strains
Strain Description Phenotype Notes References
AKR Susceptible background S Develop Th1 response regardless of dose of infective eggs [8]
Nude Athymic mice, lack of
adaptive
immune responses
S Adoptive transfer of CD4+ T cells results in parasite expulsion [19]
SCID Lack of V(D)J recombination,
no T or B cells
S Adoptive transfer of CD4+ T cells results in parasite expulsion [23]
μMT KO Lack of B cells S Th1 response development, resistance restored by neutralization
of Th1-promoting IL-12
[48]
MHCIICD11c MHCII expression restricted
to CD11c+ cells





Lack of IL-4, gender depen-
dent
S ♂ In male mice resistance can be restored by IL-13 treatment. [9], [10],
Female mice expel slightly later than WT controls. Susceptibility
can be induced by IL-13 neutralization.
R ♀ WT phenotype can be restored in both by INF-γ neutralization
IL-25 KO Lack of IL-25 S lack of MMPtype2 cells, impaired Th2 response development,
resistance restored by adoptive transfer of MMPtype2 cells
[29]
IL-10 KO Lack of IL-10 S death caused by sever immunopathology of the gut [77]
Muc5ac KO Lack of Muc5ac mucin S strong Th2 response, however, lack of Th2-regulated Mu5ac
mucin production responsible for parasite expulsion
[88]
IL-4R KO Lack of IL-4 and IL-13 re-
ceptor
S no Th2 response [90]
p55/p75 KO (C57BL/
6)
Lack of TNF-α receptor,
gender dependent
S ♂ In male mice resistance can be restored by IL-13 treatment. [11]
R ♀ In female mice susceptibility can be induced by IL-13 neutrali-
zation.
TSLPR KO Lack of TSLP receptor S Lack of Th2 response development, resistance restored by
neutralization of Th1-promoting IFN-γ
[71]
C57BL/6 Dose dependent S/R Develop Th1 response when infected with low dose of eggs [14]
BALB/k Develop Th2 when infected with high dose of eggs. [13]
BALB/c [89]





Lack of CCL11 and IL-5,
no eosinophils
R Lack of eosinophils has no effect on parasite expulsion [55]
RELMβ KO Lack of RELMβ R Decreased production of T cell-derived IFN-γ and TNF-α [91]
S susceptible, R resistant, WT wild type, ♀ female mice, ♂ male mice
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CD4+ T cells to expel infection in SCID mice [24, 25].
Interestingly, inhibition of CCR6 and CXCR3 chemokine
receptors, which are proposed to be important in gut homing
by T cells and are the most abundant chemokine receptors
expressed by CD4+ T cells in the MLN, did not prevent
expulsion of infection [25].
Analysis of intestinal intraepithelial lymphocytes (IELs)
in the large intestine of T. muris-infected resistant BALB/c
and susceptible AKR mice have shown that at the time of
expulsion (around day 21 post infection) BALB/c mice have
increased numbers of CD4+ IELs whereas IELs in AKR
animals are predominantly CD8+ [26]. Interestingly, nor-
mally resistant mice become more susceptible to infection
with age due to a decreased ability of CD4+ T cells to
respond to stimulation and to polarize into Th2 cells [27].
Taken together, the development of protective immunity
against T. muris depends almost completely on CD4+ T
lymphocytes.
Innate lymphoid cells
The hypothesis that early immune events may be important
in mounting protective responses during T. muris infection
is in agreement with recent reports on novel innate cell
populations, driven mainly by IL-25 and IL-33 production,
which can serve as a source of Th2 cytokines early during
GI parasite infections [28]. A new, IL-25-induced cell type
called multi-potent progenitor type 2 (MMPtype2) has been
suggested to be important in resistance to T. muris infection
[29]. MMPtype2 cells are linage− Sca-1+ c-kitint and can be
found in all compartments of gut-associated lymphoid tissue
(GALT) such as MLNs, Payer’s patches and caecal patches
but not in the spleen or bone marrow of IL-25-treated mice.
As their name suggests, they can give rise to many different
cell populations, i.e. monocyte, macrophages, mast cells and
basophils both in vitro and in vivo. They have also been
shown to promote T cell proliferation and differentiation
toward a Th2 phenotype in vivo. In terms of T. muris
infection, mice deficient in IL-25 (IL-25 KO mice) are
susceptible to infection, showing reduced Th2 cytokine
production and impaired mucin responses, with the pheno-
type being reversed by MPPtype2 cell transfer [29]. Thus, IL-
25 KO mice treated with IL-25-elicited MMPtype2 cells had
reduced worm numbers at day 20 post infection compared to
the untreated controls. Consistently, treated mice showed
increased production of resistance-associated IL-4, IL-5
and IL-13 in the MLNs and higher IgG1 levels in the serum
[29]. Therefore, since MMPtype2 cells have been shown to
promote development of a Th2-type response, they can be
responsible for triggering a resistance-associated T cell re-
sponse essential for T. muris expulsion. Furthermore, recent-
ly described nuocytes [30], natural helper cells [31] and
innate type 2 helper cells [32], have been shown to play
similar essential roles in early induction of Th2 immunity
during Nippostrongulus brasiliensis infection. Hence, it
remains to be seen whether these novel innate cell types
play a similar role to MPPtype2 cells during T. muris
infection.
Basophils versus dendritic cells in priming Th2 responses
during infection
Basophils can be found in draining lymph nodes upon
activation of the immune system and have recently been
shown to express MHC class II and produce Th2-inducing
cytokines such as TSLP and IL-4 [33–35]. IL-4-producing
basophils as a source of Th2-inducing cytokines could fa-
cilitate DC-mediated Th2 differentiation [36]. In addition to
acting as accessory cells aiding DC-mediated development
of Th2 responses, it has been implied in recent years that
basophils can also serve as professional antigen presenting
cells to directly induce Th2-mediated immunity [33, 35].
Indeed, there is now data indicating that basophils can
play an important role in induction of a Th2 response during
parasitic infection, including T. muris infection. Depletion
of FcεRI+ cells (which include basophils) results in reduced
Th2 responses in the intestine and a trend for increased
worm burden during T. muris infection [33]. Furthermore,
reduced levels of IL-5 and IL-13 and lack of expulsion in
TSLP receptor-deficient mice (TSLPR KO mice) is linked
with decreased numbers of basophils in these animals dur-
ing acute T. muris infection [37]. Interestingly, adoptive
transfer of basophils into TSLPR KO mice leads to a reduc-
tion in worm numbers, although expulsion is still delayed
compared to control animals [37].
Interestingly, restriction of MHCII expression to DCs is
not sufficient to generate Th2 cytokine production and
results in lack of parasite expulsion [33], suggesting that
DCs are not required for generation of Th2 responses during
T. muris infection. Additional treatment of mice with MHC
class II restricted to DCs with IFN-γ neutralizing antibody
led to the restoration of a resistant phenotype [33], suggest-
ing that DCs are capable of triggering Th2 response during
T. muris infection if Th1 development is abrogated. How-
ever, in subsequent work using different parasite infections
and alternative strategies to abrogate the function of baso-
phils and DCs, DCs were found to be crucial in the gener-
ation of parasite-induced Th2 responses. Thus, several
studies have shown that basophil depletion has no effect
on the development of Th2 responses and parasite clearance
during primary infection with N. brasiliensis [38], although
basophils do appear to be involved in responses to second-
ary infection [39]. Similarly, depletion of basophils during
Schistosoma mansoni infection does not alter the develop-
ment of Th2 responses [40, 41]. Instead, depletion of DCs
during S. mansoni infection impairs the Th2 response [40].
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Thus, whether the observed lack of requirement for DCs in
the generation of Th2 responses during T. muris is due to the
particular models used by Perrigoue et al. [33] or is a specific
observation for this parasite requires further investigation.
Moreover, it is still not clear whether basophils can serve as
an antigen presenting cells during parasite infection.
Although there is some controversy about the importance
of DCs in triggering Th2 responses during T. muris infection,
evidence exists that susceptibility/resistance to infection is
linked to differences in DC phenotype. Thus, mice that are
resistant to infection have faster DC mobilization to the site of
parasite infection than susceptible animals [42]. Th2-inducing
DCs often do not demonstrate an up-regulation of surface
activation markers and cytokine production upon antigen
encounter [43]. However, in contrast, during T. muris infec-
tion DCs from resistant mice show higher expression of
CD80/86, MHCII and CCR7 and lower endocytic activity
than DCs from susceptible mice, indicating that DCs from
resistant animals mature faster. Moreover, epithelial cells from
resistant animals have higher expression of chemokines such
as CCL2, CCL3, CCL5, CCL20 and TSLP early during
infection which correlates with the rapid mobilization of
DCs to the large intestine [42]. Indeed, mice treated with
antibodies against CCL5/CCL20 chemokines showed de-
creased DC mobilization to the large intestine [42].
Furthermore, increased frequency of CD103+ DCs,
which have been shown to have tolerogenic properties due
to elevated production of retinoic acid [44, 45] and expres-
sion of the TGF-β-activating integrin αvβ8 [46], have been
reported in the lamina propria of resistant mice [47]. How-
ever, since CD103 KO mice have similar expulsion kinetics
during both acute and chronic infection with T. muris,
expression of CD103 by these cells seems to be dispensable
for the development of protective immunity against this
parasite [47].
B cells and antibodies
B cells and B cell-produced antibodies have been suggested
in the past to be involved in the generation of protective
immunity against T. muris infection [20, 48]. IgG- and IgA-
producing cells have been detected in MLNs as early as
days 14 and 21 post infection [49, 50]. Furthermore, resis-
tant and susceptible animals differ in the type of produced
antibody class showing elevated levels of IgG1 and IgG2a,
respectively [49]. These differences in antibody responses
can be correlated with the development of distinct T cell-
mediated responses linked with different cytokine profiles,
namely the Th2 response in resistance and Th1 in suscepti-
bility to T. muris infection [50].
In addition, it has been demonstrated that B-cell deficient
mice (μMT mice) are susceptible to T. muris infection and
that their resistant phenotype can be restored by adoptive
transfer of B cells or administration of IgG from resistant
mice infected with the parasite [48]. However, adoptive
transfer of CD4+ T cells alone into SCID mice results in
successful expulsion of T. muris, indicating that expulsion
can occur in the absence of B cells [23]. Indeed, treatment of
μMT mice with anti-IL-12 antibody, which blocks the de-
velopment of the susceptibility-associated Th1 response,
also leads to parasite expulsion in these animals. Therefore,
it seems that facilitating the development of Th2 responses
via blocking of IL-12 can result in antibody-independent
expulsion of T. muris [48]. Thus, the role of B cells and
antibody during T. muris infection requires further
investigation.
Mast cells
Mast cell infiltration and activation are one of the hallmarks
of parasitic infections. Indeed, mice infected with T. muris
show an increase in mast cell numbers upon infection [51].
However, mast cell appearance at the site of infection in
many cases does not correlate with parasite expulsion; for
example, in NIH mice worms are expelled 10 days before
mastocytosis develops [51]. On the other hand, studies have
shown that transfer of IL-9-secreting T cells into mice
infected with T. muris results in increased mast cell numbers
at the site of infection, elevated serum levels of mMCP-1
(mouse mast cell protease 1) and faster parasite expulsion
[52]. Moreover, naturally mast cell-deficient mice (W/Wv
mice) demonstrate delayed T. muris expulsion [53]. How-
ever, since their wild-type counterparts can expel parasite
without any sign of mastocytosis, it seems that the role of
mast cells in generating protective immunity against T.
muris is minor [53]. Furthermore, depletion of mast cells
using neutralizing antibody against c-kit receptor, a mole-
cule critical for mast cell development, had no effect on
parasite expulsion [54]. Therefore these cells are believed to
be dispensable for the generation of protective immunity
against T. muris.
Eosinophils
Increased numbers of eosinophils are characteristic of para-
sitic helminth infections. Mice resistant to T. muris infection
have elevated numbers of these cells in the colon [55] and
MLNs [56] during infection. The induction of eosinophilia
during T. muris infection is under the control of IL-5 and the
chemokine CCL11 which work in synergy to recruit eosi-
nophils [55]. CCL11 KO mice have reduced numbers of
these cells in the colon and double knockout mice of
CXCL11 and IL-5 completely lack eosinophilia [55]. More-
over, neutralization of eosinophils with anti-IL-5 antibody
also reduced recruitment of these cells to the site of infection
[54]. It has been recently show that eosinophils found in the
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MLNs of resistant mice have an activated phenotype and
can produce IL-4 [56]. It is possible, therefore that they
could contribute to the development of the resistance-
associated Th2 response. However, reduction or depletion
of eosinophils during T. muris infection has no effect on the
development of the Th2 response and parasite expulsion
[54–56] indicating that eosinophils are dispensable for gen-
eration of the protective immune response against T. muris.
Cytokines
Susceptibility Both humans and wild-type animals are usu-
ally susceptible to infection with gastrointestinal parasites
suggesting that worms are capable of modulating immune
responses of their host to prevent expulsion. Indeed, it has
been shown that development of an inappropriate Th1 re-
sponse leads to chronic infection. Susceptible mouse strains
produce high levels of IFN-γ, IL-12 and IL-18, cytokine
characteristic of a Th1 response [5] and IFN-γ depletion in
normally susceptible animals renders them resistant [57].
Similarly, resistant mice treated with IL-12 develop chronic
infection [58]. Resistance is also associated with decreased
production of the Th1-inducing cytokine IL-18 [59]. How-
ever, since treatment of infected mice with recombinant IL-
18 resulted in impaired IL-4 and IL-13 production but did
not affect IFN-γ levels, it seems that IL-18 could have a
direct negative effect on the Th2 response during T. muris
infection [59]. In addition, neutralization of IL-18 in sus-
ceptible male IL-4 KO mice restored the ability of these
mice to expel the parasite which was associated with in-
creased production of Th2-related cytokines and a decrease
in the Th1 response [10]. Interestingly, anti-IL-18 treatment
had no effect on female IL-4 KO animals which normally
show mildly delayed T. muris clearance [10].
Additionally, mice which lack the IL-27 receptor WSX-1
(WSX-1 KO mice) do not develop chronic infection. IL-27
and WSX-1 are believed to interact in the early stages of
infection to trigger Th1 responses in susceptible animals.
WSX-1 KO animals have increased production of Th2-
associated cytokines (IL-4, IL-9, IL-13) and decreased lev-
els of Th1-associated cytokines (IFN-γ, IL-12p40) [60].
Interestingly, it has also been reported that T. muris may
produce an IFN-γ-like molecule which could potentially
contribute to regulation of the host immune response and
promotion of parasite survival [61]. Of note, prolonged
inflammatory responses observed during chronic T. muris
infection lead to the development of host-detrimental immu-
nopathology (e.g. colitis) and carry a risk of exacerbating
bystander immune responses to different agents. For exam-
ple, it has been shown that chronic T. muris infection
resulted in systemic up-regulation of pro-inflammatory
mediators, i.e. IFN-γ, TNF-α and IL-17, leading to aug-
mented brain injury in a mouse model of ischemia-induced
stroke [62]. Chronically infected animals showed accelerat-
ed platelet aggregation in the brain capillaries, increased
matrix metalloproteinase activation and microvascular inju-
ry. This exacerbated brain damage could be reversed by
CCL5 (RANTES) neutralization suggesting a role for this
Th1-related chemokine in amplifying pro-inflammatory
responses systemically [62].
Resistance Resistance-associated cytokines are usually pro-
duced against high-dose T. muris infection and lead to parasite
expulsion by triggering expulsion mechanisms such as in-
creased epithelial cell turnover, mucin production and muscle
hypercontractility. Cytokines associated with protective im-
munity to T. muris infection are Th2-type cytokines. Two
cytokines that play a major role in the resistance to infection
are IL-4 and IL-13 [63]. Mice lacking either IL-4 or IL-13 are
susceptible to infection with a high dose of T. muris which is
expelled by wild-type animals [64]. Moreover, expulsion of T.
muris infection can be stimulated in IL-4-deficient male mice
by IL-13 administration [9]. In addition, female IL-4 KOmice
on a BALB/c background which, unlike males, can clear a
high dose infection of T. muris (although delayed compared to
wild-type mice) become susceptible after IL-13 neutralization,
indicating a dominant role for IL-13 in immunity against T.
muris [9]. Both CD4+ T cells and DX5+ NK cells have been
shown to be a source of IL-13 in IL-4 KOmice, although only
depletion of the former results in complete abrogation of
parasite clearance [10].
As mentioned before, male but not female TNF-α recep-
tor deficient mice are susceptible to T. muris infection, a
phenotype that can be restored by IL-13 administration [11].
Moreover, susceptible IL-4 KO mice treated with TNF-α
are able to clear infection [65]. However, it has been ob-
served that TNF-α can also promote the development of
stronger Th1 response in normally susceptible mice [66].
Therefore, TNF-α is believed to enhance an ongoing im-
mune response, either Th1 or Th2, during infection but is
not essential for the development of immunity.
It also has been reported that IL-9 is significant in early
development of a protective immune response against T.
muris, since adoptive transfer of IL-9-producting T cells
into susceptible mice results in faster parasite expulsion,
increased intestinal mast cell infiltration and mMCP-1 levels
[52]. Indeed, the peak of IL-9 production correlates with
worm expulsion in an acute model of T. muris infection
[52]. Furthermore, immunization of mice with IL-9-OVA
complex, which leads to production of IL-9-neutralizing
antibodies in treated animals, results in impaired parasite
expulsion and decreased blood eosinophilia [67] further
indicating an important role for this cytokine in promoting
resistance to T. muris.
Other cytokines important in the development of the
protective immune response in early stages of T. muris
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infection are IL-25 and IL-33 [68, 69]. As described previ-
ously, both of these cytokines can induce innate lymphoid
cells which play an important role in the generation of
resistance-associated immunity against parasites [69]. More
specifically, IL-25 can induce generation of GALT-specific
MMPtype2 cells which have been shown to promote Th2
responses and T. muris expulsion [29]. In addition, IL-33
can induce production of IL-4, IL-9 and IL-13, cytokines
associated with a Th2-type immune response, but can also
cause increased gut pathology [68]. Mice resistant to T.
muris infection produce more IL-33 at day 3 post infection
compared to susceptible animals. Furthermore, susceptible
mice treated with recombinant IL-33 early during T. muris
infection become resistant [68]. However, the same treat-
ment applied later during infection (chronic infection) does
not result in worm expulsion. IL-33-mediated resistance
seems to be T cell-dependent because IL-33-treated SCID
mice remain susceptible to infection despite developing gut
pathology [68].
In addition to these findings, increased production of IL-
33 early during infection in resistant strains of mice has been
correlated with increased production of the Th2-inducing
cytokine TSLP [68]. Indeed, disruption of the TSLP-TSLPR
interaction results in impaired Th2 cytokine production and
susceptibility to T. muris [70, 71]. This ineffective parasite
expulsion has been associated with increased production of
pro-inflammatory cytokines such as IL-12/23 (detected by
enhanced expression of the IL-12 and IL-23 common sub-
unit p40), IFN-γ and IL-17A, and more severe gut inflam-
mation [71]. Neutralization of IFN-γ resulted in restoration
of a resistant phenotype in TSLPR KO mice [71] indicating
an important role for TSLP in early priming of the immune
response against T. muris towards the resistance-associated
Th2 response.
In summary, IL-4 and/or IL-13 accompanied by a range
of Th2-related cytokines induce changes in intestinal envi-
ronment such as hypercontractility of gut muscle, increased
mucus production and turnover of epithelial cells which
contribute to efficient expulsion of T. muris (discussed fur-
ther in the “Mechanisms of expulsion” section).
Regulation of the immune response during infection
Prolonged infection with gastrointestinal parasites, if not
properly regulated, can result in severe damage to surround-
ing tissues. Immunopathology associated with susceptibility
to T. muris infection can be characterised by severe trans-
mural inflammation of the colon. Mucosal and submucosal
inflammation results in destruction of normal crypt archi-
tecture and a subsequent wasting disorder [72]. Interesting-
ly, changes in the gut physiology and architecture during
chronic T. muris infection are similar to those observed
during inflammatory bowel disease (IBD). In addition,
phenotypic and translational similarities between chronic
T. muris infection and mouse models of IBD and human
IBD have been recently shown by transcriptional profiling
studies [72]. It is somehow surprising therefore that in recent
years clinical studies have shown that repeated oral admin-
istration of Trichuris suis eggs, a related parasite which
normally causes trichuriasis in pigs, leads to remission of
IBD symptoms in some patients [73, 74]. However, the
safety of such practices has been questioned, with worries
about the potential development of persistent chronic infec-
tion with T. suis [75]. Nonetheless, the immune response
generated against parasites is believed to have a regulatory
effect on responses to unrelated antigens such as bacterial
flora which is a likely causative agent of IBD [76]. There-
fore, investigating the mechanisms behind such regulation
may eliminate potentially harmful elements of infection,
leading to the development of new therapies for bowel
disorders.
However, it is still unclear how the immune system is
regulated during T. muris infection. A cytokine that plays an
important role in resistance to T. muris infection is the
regulatory molecule IL-10, with mice deficient in IL-10
becoming susceptible to T. muris infection and developing
severe and fatal intestinal pathology [77]. In addition, TGF-
β seems to be significant in regulating responses to T. muris.
Recent studies have shown that CD4-dnTGF-βRII mice,
whose CD4+ T cell have reduced ability to respond to
TGF-β due to expression of truncated version of TGF-β
receptor II (dnTGF-βII), have increased worm burden and
down-regulated levels of IL-4 and IL-9 but normal IL-13
production [78]. It has also been shown that Tregs may play
an important role in T. muris infection. A specific isolate of
T. muris, isolate S, causes chronic infection in normally
resistant C57BL/6 mouse strain that is associated with in-
creased numbers of Foxp3+ Tregs in the gut of these mice
[17]. Moreover, treatment with antibodies against GITR
(glucocorticoid-induced TNF-α–related) molecule, which
target Treg function, results in decreased worm burden and
modulation of the immune response [17]. Interestingly,
stimulation of bone marrow-derived macrophages and den-
dritic cells with S isolate excretory-secretory antigen results
in increased production of IL-6 and IL-10 [79]. Since IL-6
has been shown to up-regulate IL-10 production [80] and
IL-10 is important in controlling the development of fatal
pathology during T. muris infection [77], it is possible that
the S isolate of T. muris stimulates a more regulatory envi-
ronment to aid its survival. Moreover, a relatively new
subset of regulatory cells called iTR35 (CD4
+Foxp3−Ebi3+-
p35+IL-10−TGF-β−) has been proposed to be important in
regulating immune responses during T. muris infection [81].
These cells are highly suppressive in vitro and in vivo in an
IL-35-dependent but IL-10- and TGF-β-independent man-
ner, and can be detected in the large intestine during T. muris
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infection [81]. Taken together, regulatory cells and cyto-
kines seem to be important in modulating effector immune
responses during T. muris infection. However, more work is
required to further assess regulatory mechanisms operating
during T. muris infection.
Mechanisms of expulsion
Epithelial cell turnover
Chronic infection with T. muris has been associated with
crypt hyperplasia accompanied by both increased epithelial
cell proliferation and apoptosis [82]. Both of these processes
seem to be controlled by the pro-inflammatory cytokine
IFN-γ and are believed to counterbalance each other in an
attempt to control excessive crypt elongation in chronically
infected animals [82, 83]. On the other hand, such dramatic
changes are not observed in the gut of resistant mice. It has
been demonstrated that resistant animals have accelerated
epithelial cell turnover, a mechanism which is directly
linked to faster parasite expulsion [84]. These findings led
to a model referred to as the ‘epithelial escalator’, where
epithelial cells move from the bottom of the crypt (prolifer-
ation zone) to its top (shedding zone), moving the parasite
embedded in the epithelial layer towards the lumen where
the epithelium and parasite are shed (Fig. 2). Therefore,
mice that up-regulate epithelial cell turnover earlier during
the infection (e.g. BALB/c) have an advantage over animals
which fail to do so (e.g. AKR mice) [84]. Interestingly,
differences in epithelial cell turnover between resistant and
susceptible mice are due to differences in their immune
responses and cytokine profiles, with Th1 and Th2
responses associated with down- and up-regulation of epi-
thelial turnover speed, respectively. Studies in IL-4 KO and
IL-13 KO mice have shown that acceleration in epithelial
cell turnover is IL-13-dependent but IL-4-independent. On
the other hand, IFN-γ and CXCL10 (IFN-γ-induced protein
10), both associated with a Th1 response and susceptibility
to T. muris infection, seem to be responsible for epithelial
cell turnover down-regulation [84]. Both AKR and SCID
mice when treated with anti-CXCL10 antibodies showed an
earlier up-regulation in epithelial cell turnover and parasite
expulsion, further highlighting the importance of this mech-
anism in T. muris clearance [84]. In addition, recent studies
have suggested a role for indoleamine 2,3-dioxygenase
(IDO), an enzyme responsible for tryptophan degradation
that is up-regulated during chronic T. muris infection, in
controlling epithelial cell turnover ratio [85]. Normally sus-
ceptible SCID mice when treated with IDO inhibitor dem-
onstrated faster epithelial cell turnover and parasite
expulsion suggesting that IDO can also directly affect turn-
over upon T. muris infection [85]. Taken together, these data
underline epithelial cell turnover as a major mechanism of T.
muris expulsion.
Mucin production by goblet cells
Goblet cells are major producers of mucins (the major
protein component of mucus) and form an important ele-
ment of the innate defence in the gastrointestinal tract.
Goblet cell hyperplasia is observed during T. muris infection
in both resistance and susceptible animals [86]. However,
recent work by Hasnain et al. has shown that there is a
significant variation in the type of mucin produced by
intestinal goblet cells between resistant and susceptible mice
[87–89]. Up-regulation of the mucin Muc2 was only ob-
served in resistant animals and correlated with parasite
expulsion. Moreover, Muc2-deficient mice demonstrated
delayed parasite clearance compared to their wild-type
counterparts [87]. Interestingly, Muc5ac, a mucin normally
produced in airways and stomach but not the intestine, was
also detected in resistant animals shortly before T. muris
expulsion [87, 88]. Mice deficient in Muc5ac were suscep-
tible to infection despite generating a strong Th2 response
and stayed unable to expel the parasite even after treatment
with IFN-γ neutralizing antibody which further enhanced
the Th2 response [88]. Interestingly, treatment of adult T.
muris worms with Muc5ac had detrimental effect on worm
viability, as measured by parasite ATP levels [88]. These
results indicate that certain mucins can have a direct dam-
aging effect on worms.
The physical properties of the mucus barrier also
changes during infection and correlates with responses
to infection. Thus, the mucus barrier in resistant animals
is less permeable, thicker and more highly charged than
in susceptible mice [87, 89]. The intermediate barrier,
rich in glycoproteins, shows higher levels of Muc4,
Muc13 and Muc17 upon acute infection with T. muris.
Interestingly, higher expression of Muc17 has also been
observed in chronically infected animals [89]. Alteration
in mucin glycosylation has also been reported between
resistant and susceptible animals with the former show-
ing higher expression of D-GalNAc glycan at the time
of parasite expulsion [89]. Additionally, resistant ani-
mals show activation of the transcription factors atonal
homolog 2 (Math-1) and SAM pointed domain contain-
ing ETS transcription factor (Spdef) which promote
stem cell differentiation towards a secretory cell pheno-
type [89]. Hence, changes in the type, amount and state
(charge and glycosylation) of mucin appear important in
mediating immunity to T. muris.
Another goblet cell-derived molecule, resistin-like mole-
cule β (RELMβ), has also been associated with immunity to
T. muris infection with increased levels of this protein found
in resistant animals [90]. Induction of RELMβ correlates
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Fig. 2 Epithelial cell turnover. Epithelial cells proliferate at the bottom
of the crypt in the proliferation zone and subsequently migrate up the
crypt through transit zone. When they reach the top of the crypt
(shedding zone), they are removed. In resistance, mice infected with
T. muris have accelerated epithelial cell turnover hindering worm
ability to stay in the crypts attached to the epithelium. With faster
epithelial cell turnover the parasite is moved to the top of the crypt,
detached from the epithelium with shedded epithelial cells and subse-
quently expelled
Fig. 3 Mechanisms of T. muris expulsion. In resistance, generation of
a Th2-type of a response is characterised by increased production of
IL-4, IL-9 and IL-13. Basophils (Baso) and innate lymphoid cells (ILC)
have been suggested to act as an early source of Th2 cytokines and to
facilitate a Th2-type response development. Both increased epithelial
cell (EC) turnover and increased production of mucins have been
shown to be IL-13-dependent. Up-regulation of mucin secretion results
in the thickening of a mucus layer which makes it more difficult for the
parasite to stay attached to the epithelium. Also, mucus of resistant
animals is rich in mucins such as Muc5ac which have a direct
detrimental effect on worm viability. Moreover, IL-9 induces an in-
crease in muscle contractility in the gut facilitating parasite expulsion.
On the contrary, in susceptibility development of a Th1 response and
production of IFN-γ result in slower EC turnover and muscle contrac-
tility, decreased Muc2 and lack of Muc5ac production. Furthermore, an
exacerbated Th1 response eventually leads to immunopathology
development resembling colitis. In addition, regulatory T cells
(Treg) have been implicated in promoting susceptibility to infec-
tion with T. muris
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with the production of Th2 cytokines. Indeed, IL-4 receptor
KO mice, which lack both IL-4 and IL-13 signal transduc-
tion, but not IL-4 KO mice demonstrate impaired RELMβ
expression, indicating an important role for IL-13 but not
IL-4 in inducing RELMβ production [90]. It has been also
suggested that RELMβ can have a direct negative effect on
worms by affecting parasite chemosensory apparatus and
thus impairing chemotaxis [90]. However, since RELMβ
KO mice expel acute T. muris infection normally, RELMβ
seems to be dispensable for the generation of Th2 response
in resistant animals [91].
Conversely, studies have shown that RELMβ can
actually promote chronic T. muris infection development
[91]. Thus, RELMβ can facilitate development of a Th1
response via activation of intestinal macrophages which
produce pro-inflammatory cytokines such as IL-12/23,
IL-6 and TNF-α [91]. RELMβ KO mice show reduced
intestinal inflammation associated with decreased pro-
duction of T cell-derived IFN-γ and TNF-α, and fail
to establish chronic infection [91].
Taken together, goblet cells and their products are impor-
tant elements of the host immune responses against T. muris
and seem to be indispensable for effective parasite clearance
from the intestine.
Muscle hypercontractility
It has been demonstrated that increased contractility of
smooth muscle cells lining the wall of the intestine can
be an important mechanism of gastrointestinal parasite
expulsion. Studies on the small intestine-dwelling para-
site Trichinella spiralis have shown that parasite expul-
sion is associated with muscle hypercontractility, via a
STAT-6 and CD40-CD40L signalling-dependent mecha-
nism controlled by the immune system [92, 93]. Inter-
estingly, increased muscle contractility has been also
related to increased resistance to T. muris infection
[94]. This process has been reported to be controlled
by IL-9, an important cytokine in resistance to T. muris.
Indeed, neutralization of IL-9 by antibody treatment or
by immunization with the OVA-IL-9 complex resulted
in decreased smooth muscle contractility and the lack of
parasite expulsion [94]. Moreover, susceptible AKR
mice chronically infected with T. muris have been
reported to have decreased muscle contractility which
could be partially restored by treatment with the immu-
nosuppressive drug dexamethason [95]. Thus, smooth
muscle hypercontractility appears to be an important
immune-mediated mechanism of T. muris expulsion.
Taken together, faster epithelial cell turnover, increased mu-
cus production and muscle contractility are three known and
characterised as immune-mediated mechanisms of T. muris
expulsion (Fig. 3).
Conclusion
T. muris, as a mouse model of T. trichiura in humans, has
contributed greatly to an increase in our understanding of the
relation between gastrointestinal parasite and its host in terms
of generated immune responses and expulsion mechanisms.
Moreover, knowledge acquired while studying T. murismodel
may be applied to other soil-transmitted gastrointestinal para-
site infections. This is especially important since despite their
evident public-health importance, soil-transmitted gastrointes-
tinal infections remain largely neglected by medical and in-
ternational societies. Part of the problem is that most affected
individuals are also the world’s most impoverished and since
helminth infections cause chronic illnesses most people can-
not afford the prolonged and repeated treatment. Moreover,
people in endemic areas are usually infected with more than
one parasite causing more obscure and hard to diagnose
clinical presentation [2]. Treatment of gastrointestinal infec-
tions is limited to chemotherapy with antihelminthics, with
widespread and frequent use carrying the risk of the parasites
developing drug resistance [96]. Moreover, even though prog-
ress in vaccine construction has been made in recent years
[97], insufficient knowledge of how immune responses are
induced and regulated during parasite infections impairs fast
advancement in this field. Therefore, it is essential to increase
our understanding of immune mechanisms responsible for
controlling the development and expulsion of helminth infec-
tions which can subsequently lead to development of novel
therapies.
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